Phase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study).
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Cariprazine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- 11 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2009 New trial record